PFG Investments LLC Has $395,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

PFG Investments LLC reduced its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 17.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 32,671 shares of the pharmacy operator’s stock after selling 6,893 shares during the quarter. PFG Investments LLC’s holdings in Walgreens Boots Alliance were worth $395,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Capital World Investors lifted its holdings in shares of Walgreens Boots Alliance by 57.5% in the 1st quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock worth $630,334,000 after purchasing an additional 10,612,373 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its stake in shares of Walgreens Boots Alliance by 6.1% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,718,659 shares of the pharmacy operator’s stock valued at $32,882,000 after buying an additional 156,484 shares in the last quarter. Schroder Investment Management Group lifted its stake in shares of Walgreens Boots Alliance by 1.2% in the fourth quarter. Schroder Investment Management Group now owns 2,249,654 shares of the pharmacy operator’s stock valued at $58,738,000 after buying an additional 27,634 shares in the last quarter. Ariel Investments LLC grew its holdings in shares of Walgreens Boots Alliance by 25.3% during the first quarter. Ariel Investments LLC now owns 1,839,987 shares of the pharmacy operator’s stock valued at $39,909,000 after buying an additional 371,386 shares during the last quarter. Finally, Hsbc Holdings PLC increased its position in shares of Walgreens Boots Alliance by 12.9% during the fourth quarter. Hsbc Holdings PLC now owns 1,732,428 shares of the pharmacy operator’s stock worth $45,062,000 after acquiring an additional 197,370 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Up 1.1 %

Walgreens Boots Alliance stock opened at $8.84 on Friday. The firm has a 50 day moving average price of $10.55 and a 200-day moving average price of $15.27. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance, Inc. has a twelve month low of $8.46 and a twelve month high of $27.05. The company has a market capitalization of $7.63 billion, a P/E ratio of -1.31, a P/E/G ratio of 0.93 and a beta of 0.70.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The firm had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. During the same period last year, the company posted $1.00 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 2.8% on a year-over-year basis. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 2.87 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were given a dividend of $0.25 per share. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a yield of 11.31%. Walgreens Boots Alliance’s dividend payout ratio is presently -14.84%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on WBA. Evercore ISI cut their price target on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating for the company in a research note on Friday, June 28th. JPMorgan Chase & Co. cut their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Barclays lowered their price target on Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a research report on Tuesday, July 23rd. Morgan Stanley cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a report on Friday, June 28th. Finally, Truist Financial lowered their target price on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday, June 28th. Four analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $14.73.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.